Posted at: 05/13/2013 6:47 AM
Researchers at UCLA are studying an experimental new drug for breast cancer that could slow cancer growth dramatically and put a stop to hair loss and nausea associated with chemotherapy.
It’s called palbociclib and it targets a certain protein that causes breast cancer cells to spread. In initial tests, the drug helped to stop cancer growth in its tracks. Doctors say it could also help reduce the use of poisonous chemo drugs.
The FDA has named it a breakthrough drug which could speed up the approval process to make it available to the public.